TAT-N15

TAT-N15 is a p55PIK inhibitor with demonstrated anti-inflammatory and neuroprotective effects, suppressing key pathways including Akt, STAT3, and NF-κB. It is applicable for research in acute conjunctivitis, allergic rhinitis, COPD, and stroke, supported by findings from in vitro and in vivo experimental models.